The latest closing stock price for Humacyte as of November 20, 2024 is 4.41.
An investor who bought $1,000 worth of Humacyte stock at the IPO in 2020 would have $-544 today, roughly -1 times their original investment - a -17.82% compound annual growth rate over 4 years.
The all-time high Humacyte stock closing price was 16.99 on September 01, 2021.
The Humacyte 52-week high stock price is 9.97, which is 126.1% above the current share price.
The Humacyte 52-week low stock price is 2.43, which is 44.9% below the current share price.
The average Humacyte stock price for the last 52 weeks is 4.89.
An investor who bought $1,000 worth of Humacyte stock at the IPO in 2020 would have $-544 today, roughly -1 times their original investment - a -17.82% compound annual growth rate over 4 years.
The all-time high Humacyte stock closing price was 16.99 on September 01, 2021.
The Humacyte 52-week high stock price is 9.97, which is 126.1% above the current share price.
The Humacyte 52-week low stock price is 2.43, which is 44.9% below the current share price.
The average Humacyte stock price for the last 52 weeks is 4.89.